EUVIMEDEUVIMED entdecken
Crossref

Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia

Zaineb Hamzaoui iD, Sana Ferjani, Lamia Kanzari, Roua Ben Ali, Latifa Charaa, Ichrak Landolsi, Ines Medini, Sarra Chammam, Salma Abid, Asma Ferjani, Dhouha Kebaier, Ahmed Fakhfakh und 4 weitere

Acta Microbiologica et Immunologica Hungarica · 2024

DOI: 10.1556/030.2024.02247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2024. Verfasst von Zaineb Hamzaoui und 15 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, Tunis 1007, Tunisia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Ministry of Higher Education and Scientific Research of Tunisia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The JN.1 sub-variant is a new variant of the SARS-CoV-2 Omicron strain, derived from the BA.2.86 sub-variant. It was first detected in late 2023 and has quickly spread to many countries, becoming the most prevalent variant in some regions. JN.1 exhibits a unique mutation (L455S) in the spike protein compared to the BA.2.86 lineage, which may affect its transmissibility and immune evasion capabilities. JN.1 has been designated as a “variant of interest” by the World Health Organization due to its rapidly increasing spread and is being closely monitored for its impact on the COVID-19 pandemic. This study describes the emergence of SARS-CoV-2 JN.1 sub-variant in Tunisia, and reports its mutation profiles. Nasopharyngeal samples collected over a four-month period (October 2023 to January 2024) were subjected to RNA extraction and real-time RT-PCR confirmation of SARS-CoV-2 infection. The whole-genome sequencing was performed by an iSeq 100 sequencer and COVIDSeq kit reagents (Illumina, USA). Mutation analysis, using the NextClade platform and GISAID database, revealed the presence of JN.1 in 15 out of 80 positive cases (18.75%) during the study period. The emergence of JN.1 highlights the ongoing evolution of SARS-CoV-2 and the need for continued surveillance and research to better understand the characteristics and impact of emerging variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2MutationTunisiaHumansMaleFemaleMiddle AgedSpike Glycoprotein, CoronavirusAdultGenome, ViralAgedWhole Genome SequencingPhylogeny

Stichwörter der Autor:innen

BA.2.86JN.1 sub-variantL455S mutationOmicronSARS-CoV-2

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • 1University of Tunis El Manar, Faculty of Medicine of Tunis, LR99ES09, Tunis 1007, Tunisia.
  • 2Charles Nicolle Hospital, Laboratory of Microbiology, Tunis 1006, Tunisia.
  • 3National Center Chalbibelkahia of Pharmacovigilance of Tunis, Laboratory of Clinical Pharmacology, 9 Avenue Dr. Zouhaier Essafi 1006 Bab Souika, Tunis, Tunisia.
  • 4University of Tunis El Manar, Faculty of Medicine of Tunis, LR16SP02, 1007 Tunis, Tunisia.

ORCID-Profile: Zaineb Hamzaoui

Förderung

  • Ministry of Higher Education and Scientific Research of Tunisia

Zitieren

APA

Hamzaoui, Z., Ferjani, S., Kanzari, L., Ben Ali, R., Charaa, L., Landolsi, I., Medini, I., Chammam, S., Abid, S., Ferjani, A., Kebaier, D., Fakhfakh, A., Bouslah, Z., Ben Sassi, M., Trabelsi, S., & Boutiba-Ben Boubaker, I. (2024). Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2024.02247

Vancouver

Hamzaoui Z, Ferjani S, Kanzari L, Ben Ali R, Charaa L, Landolsi I, et al. Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia. Acta Microbiologica et Immunologica Hungarica. 2024. doi:10.1556/030.2024.02247

BibTeX
@article{Hamzaoui2024,
  author = {Hamzaoui, Zaineb and Ferjani, Sana and Kanzari, Lamia and Ben Ali, Roua and Charaa, Latifa and Landolsi, Ichrak and Medini, Ines and Chammam, Sarra and Abid, Salma and Ferjani, Asma and Kebaier, Dhouha and Fakhfakh, Ahmed and Bouslah, Zoubeir and Ben Sassi, Mouna and Trabelsi, Sameh and Boutiba-Ben Boubaker, Ilhem},
  title = {Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2024},
  doi = {10.1556/030.2024.02247}
}
Kostenlos starten →